ARVO 2014 Keynote with Jean Bennett (videos)
Seeing the Light with Retinal Gene Therapy: Things you wish you’d known early on your way to late-stage trials
Jean Bennett, MD, PhD, FARVO, FM Kirky Professor of Molecular Ophthalmology at the University of Pennsylvania School of Medicine presented the closing talk as part of the ARVO/Alcon Keynote Series at the ARVO 2014 Annual Meeting in Orlando, Fla. on May 8, 2014.
Bennett brought various members of her team to the podium to discuss their experiences and unique perspectives as they worked together to develop late-stage retinal gene therapy trials. The group also including a young patient with Lebers Congenital Amaurosis, whose sight was restored several years ago, thanks to Bennett and her team.
The resulting talks are an enlightening and accessible account of what it takes to organize a late-stage trial, including the funding environment, design, lessons learned and more. Researchers, technicians, clinicians, patients, advocacy groups, funders and others will find the presentations useful.